Meta-Analysis
Copyright ©The Author(s) 2024.
World J Diabetes. Apr 15, 2024; 15(4): 783-792
Published online Apr 15, 2024. doi: 10.4239/wjd.v15.i4.783
Table 1 General data and quality evaluation of the included studies
Ref.
Country
Instrument
Groups
Number
Gender (male/female, n)
Age (yr)
3D-STI parameters and LVEF
NOS score
Tadic et al[4], 2015SerbiaGE Vivid E7DM5026/2452.00 ± 8.00GLS, GCS, GRS, GAS, LVEF8
NC5024/2650.00 ± 7.00
Wang et al[5], 2015ChinaGE Vivid E9DM4624/2263.10 ± 9.80GLS, GCS, GRS, GAS, LVEF7
NC4021/1965.50 ± 5.90
Zhang et al[6], 2013ChinaGE Vivid E9DM-a13115/1661.00 ± 9.00GLS, GCS, GRS, GAS, LVEF8
DM-b13721/1660.00 ± 10.00
NC6330/3358.00 ± 10.00
Enomoto et al[7], 2016JapanAplio-ArtidaTMDM7753/2456.00 ± 15.00GLS, GRS, GCS, LVEF7
NC3518/1752.00 ± 16.00
Wang et al[8], 2015ChinaGE Vivid E9DM-a23618/1864.40 ± 7.90GLS, GRS, GCS, GAS8
DM-b24121/2065.70 ± 9.00
DM-c24622/2463.10 ± 9.80
NC3618/1866.80 ± 8.40
Yang et al[9], 2021ChinaGE Vivid E9DM-a32819/951.42 ± 8.94GLS, GRS, GCS, LVEF8
DM-b31913/652.16 ± 9.22
NC2718/949.93 ± 8.28
Conte et al[10], 2013ItalyGE Vivid E7DM-a44423/2160.90 ± 6.60GLS, GRS, GCS, GAS7
DM-b42717/1056.20 ± 7.80
NC2413/1158.40 ± 9.40
Abomandour et al[11], 2022EgyptVivid E2013DM-a53117/1432.94 ± 5.56GLS, GRS, GCS, LVEF7
DM-b53118/1328.74 ± 9.35
NC3111/2030.32 ± 9.53
Wang et al[12], 2022ChinaGE Vivid E9DM-a64021/1964.40 ± 7.90GLS, GRS, GCS, GAS, LVEF8
DM-b64021/1960.80 ± 8.10
NC4020/2061.90 ± 6.90